<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01530477</url>
  </required_header>
  <id_info>
    <org_study_id>101.02-2011-GES-0005</org_study_id>
    <nct_id>NCT01530477</nct_id>
  </id_info>
  <brief_title>DXA Precision and Accuracy Comparison Study</brief_title>
  <acronym>DXA P&amp;A</acronym>
  <official_title>DXA Precision and Accuracy Comparison Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>GE Healthcare</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>GE Healthcare</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is being conducted to examine the performance of three common DXA machines (1)
      Lunar iDXA, (2) Lunar Prodigy and (3) Hologic Discovery A in measuring bone density and body
      fat.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      For this study, two specific groups of volunteers will be recruited. In one group, the scan
      will measure bone density and in the other group the scan will measure fat. The groups will
      be broken into weight groups to determine which of the scanners the subject will be scanned
      on. Subjects will have the option to participate in either one or both groups.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Early termination due to inability to meet enrollment for &gt;350lb weight class
  </why_stopped>
  <start_date>January 2012</start_date>
  <completion_date type="Actual">December 2012</completion_date>
  <primary_completion_date type="Actual">December 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Screening</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Short Term Precision Comparison Across Three DXA Devices</measure>
    <time_frame>Less than 6 months</time_frame>
    <description>BMD precision will be reported across three DXA devices in major skeletal and body composition sites. The short-term precision was calculated as RMS-SD (root mean square standard deviation) over the mean for each cohort. The skeletal cohort will not have short-term precision value for body composition indexes due to the different region of measurement. The same will apply to the body composition cohort. As the result, the &quot;Skeletal &amp; Body Composition&quot; cohort identified in participant flow and overall study summary will not have an analysis provided.</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">82</enrollment>
  <condition>Osteopenia</condition>
  <arm_group>
    <arm_group_label>Skeletal</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Recruitment for each cohort will include approximately equal male/female split (no gender bias). Depending on the weight category, for each cohort, a minimum of 30 adult subjects will be measured on two of three systems [Lunar Prodigy (GEHC), Lunar iDXA (GEHC) and Discovery A (Hologic)], and 60 will be measured on all three systems [Lunar Prodigy (GEHC), Lunar iDXA (GEHC) and Discovery A (Hologic)],(total of evaluable 90 subjects).
** Subjects can enroll in both Skeletal and Body Composition cohorts. Analysis will be performed within each cohort.**</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Body Composition</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Recruitment for each cohort will include approximately equal male/female split (no gender bias). Depending on the weight category, for each cohort, a minimum of 30 adult subjects will be measured on two of the three systems [Lunar Prodigy (GEHC), Lunar iDXA (GEHC) and Discovery A (Hologic)], and 60 will be measured on all three systems [Lunar Prodigy (GEHC), Lunar iDXA (GEHC) and Discovery A (Hologic)], (total of evaluable 90 subjects).
** Subjects can enroll in both Skeletal and Body Composition cohorts. Analysis will be performed within each cohort.**</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Skeletal &amp; Body Composition</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>&quot;Skeletal and Body Composition&quot; was not a cohort that was actively recruited to, it is a cohort for reporting purposes. Subjects will be measured on two of three systems [Lunar Prodigy (GEHC), Lunar iDXA (GEHC) and Discovery A (Hologic)]Subjects were able to consent and enroll to both Skeletal and Body Composition cohorts and these subjects will be counted for under this joint cohort.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Lunar Prodigy (GEHC)</intervention_name>
    <description>Lunar Prodigy (GEHC) used to obtain Skeletal, and/or Body Composition measurements</description>
    <arm_group_label>Skeletal</arm_group_label>
    <arm_group_label>Body Composition</arm_group_label>
    <arm_group_label>Skeletal &amp; Body Composition</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Lunar iDXA (GEHC)</intervention_name>
    <description>Lunar iDXA (GEHC) used to obtain Skeletal, and/or Body Composition measurements</description>
    <arm_group_label>Skeletal</arm_group_label>
    <arm_group_label>Body Composition</arm_group_label>
    <arm_group_label>Skeletal &amp; Body Composition</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Discovery A (Hologic</intervention_name>
    <description>Discovery A (Hologic) used to obtain Skeletal, and/or Body Composition measurements</description>
    <arm_group_label>Skeletal</arm_group_label>
    <arm_group_label>Body Composition</arm_group_label>
    <arm_group_label>Skeletal &amp; Body Composition</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Men and women &gt; 20 years old

          2. Willing to provide consent

          3. Falls into one of three weight categories, with minimum 30 subjects per category.

               -  Less than 200 lbs.

               -  200 (inclusive) to less than 350 lbs.

               -  350 (inclusive) to less than 450 lbs.

          4. Participate in only one weight category in either skeletal or body composition cohort,
             or both.

        Exclusion Criteria:

          1. Inability to remain still for the duration of the DXA scans as judged by study
             Investigator.

          2. Un-removable internal / external scan artifacts e.g. plaster casts, metal rodding
             naso-gastric tubes, etc.

          3. Females of childbearing potential* with actual (confirmed by positive urine pregnancy
             test) or suspected (based on study Investigator evaluation despite a negative urine
             test) pregnancy.

          4. Subject had already given consent to participate in any aspect of this study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Paul Miller, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Study site</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Colorado Center for Bone Research</name>
      <address>
        <city>Lakewood</city>
        <state>Colorado</state>
        <zip>80337</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 6, 2012</study_first_submitted>
  <study_first_submitted_qc>February 9, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 10, 2012</study_first_posted>
  <results_first_submitted>June 26, 2013</results_first_submitted>
  <results_first_submitted_qc>September 23, 2014</results_first_submitted_qc>
  <results_first_posted type="Estimate">September 25, 2014</results_first_posted>
  <last_update_submitted>August 8, 2016</last_update_submitted>
  <last_update_submitted_qc>August 8, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 16, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Bone mineral density</keyword>
  <keyword>weight</keyword>
  <keyword>body composition</keyword>
  <keyword>DEXA</keyword>
  <keyword>DXA</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bone Diseases, Metabolic</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>A total of 17 subjects consented for the Skeletal Cohort only. A total of 12 subjects consented for the Body Composition Cohort only. A total of 53 subjects consented to participate in both the Skeletal and Body Composition cohorts. Recruitment occurred at the primary site from January to December 2012.</recruitment_details>
      <pre_assignment_details>Subjects were able to consent and participate in one or both cohorts (Outcome Measure Reporting Groups: Skeletal and Body Composition). GE prematurely ended the study with 82 consented individuals but a total of 135 scans were acquired across the cohorts.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Skeletal</title>
          <description>Recruitment for each cohort will include approximately equal male/female split (no gender bias). Depending on the weight category, for each cohort, a minimum of 30 adult subjects will be measured on two of the three systems, and 60 will be measured on all three systems (total of evaluable 90 subjects). Subjects willing to participate in Skeletal &amp; Body Composition are counted towards the 90 evaluable subject requirement of the protocol for the Skeletal Cohort.</description>
        </group>
        <group group_id="P2">
          <title>Body Composition Only</title>
          <description>Recruitment for each cohort will include approximately equal male/female split (no gender bias). Depending on the weight category, for each cohort, a minimum of 30 adult subjects will be measured on two of the three systems, and 60 will be measured on all three systems (total of evaluable 90 subjects). Subjects willing to participate in Skeletal &amp; Body Composition are counted towards the 90 evaluable subject requirement of the protocol for the Body Composition Cohort.</description>
        </group>
        <group group_id="P3">
          <title>Skeletal &amp; Body Composition</title>
          <description>&quot;Skeletal &amp; Body Composition&quot; was not a cohort that was actively recruited to, it is a cohort for reporting purposes. Subjects were able to consent and enroll to both Skeletal and Body Composition cohorts and these subjects will be counted for under this joint cohort.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="17">17 subjects consented to the Skeletal cohort only.</participants>
                <participants group_id="P2" count="12">12 subjects consented to the Body Composition cohort only.</participants>
                <participants group_id="P3" count="53">53 subjects consented to both the Skeletal and body Composition cohorts.</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="17">17 subjects completed imaging in the Skeletal cohort only.</participants>
                <participants group_id="P2" count="12">12 subjects completed imaging in the Body Composition cohort only.</participants>
                <participants group_id="P3" count="53">53 subjects completed the imaging in both the Skeletal and Body Composition cohorts.</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Skeletal</title>
          <description>Recruitment for each cohort will include approximately equal male/female split (no gender bias). Depending on the weight category, for each cohort, a minimum of 30 adult subjects will be measured on two of the three systems, and 60 will be measured on all three systems (total of evaluable 90 subjects). Subjects willing to participate in Skeletal &amp; Body Composition are counted towards the 90 evaluable subject requirement of the protocol for the Skeletal Cohort.</description>
        </group>
        <group group_id="B2">
          <title>Body Composition</title>
          <description>Recruitment for each cohort will include approximately equal male/female split (no gender bias). Depending on the weight category, for each cohort, a minimum of 30 adult subjects will be measured on two of the three systems, and 60 will be measured on all three systems (total of evaluable 90 subjects). Subjects willing to participate in Skeletal &amp; Body Composition are counted towards the 90 evaluable subject requirement of the protocol for the Body Composition Cohort.</description>
        </group>
        <group group_id="B3">
          <title>Skeletal and Body Composition</title>
          <description>&quot;Skeletal and Body Composition&quot; was not a cohort that was actively recruited to, it is a cohort for reporting purposes. Subjects were able to consent and enroll to both Skeletal and Body Composition cohorts and these subjects will be counted for under this joint cohort.</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="17"/>
            <count group_id="B2" value="12"/>
            <count group_id="B3" value="53"/>
            <count group_id="B4" value="82"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="17"/>
                    <measurement group_id="B2" value="12"/>
                    <measurement group_id="B3" value="53"/>
                    <measurement group_id="B4" value="82"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="25"/>
                    <measurement group_id="B4" value="39"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="28"/>
                    <measurement group_id="B4" value="43"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Short Term Precision Comparison Across Three DXA Devices</title>
        <description>BMD precision will be reported across three DXA devices in major skeletal and body composition sites. The short-term precision was calculated as RMS-SD (root mean square standard deviation) over the mean for each cohort. The skeletal cohort will not have short-term precision value for body composition indexes due to the different region of measurement. The same will apply to the body composition cohort. As the result, the &quot;Skeletal &amp; Body Composition&quot; cohort identified in participant flow and overall study summary will not have an analysis provided.</description>
        <time_frame>Less than 6 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Skeletal</title>
            <description>Recruitment for each cohort will include approximately equal male/female split (no gender bias). Depending on the weight category, for each cohort, a minimum of 30 adult subjects will be measured on two of the three systems, and 60 will be measured on all three systems (total of evaluable 90 subjects). Subjects willing to participate in Skeletal &amp; Body Composition are counted towards the 90 evaluable subject requirement of the protocol for the Skeletal Cohort.</description>
          </group>
          <group group_id="O2">
            <title>Body Composition Only</title>
            <description>Recruitment for each cohort will include approximately equal male/female split (no gender bias). Depending on the weight category, for each cohort, a minimum of 30 adult subjects will be measured on two of the three systems, and 60 will be measured on all three systems (total of evaluable 90 subjects). Subjects willing to participate in Skeletal &amp; Body Composition are counted towards the 90 evaluable subject requirement of the protocol for the Body Composition Cohort.</description>
          </group>
        </group_list>
        <measure>
          <title>Short Term Precision Comparison Across Three DXA Devices</title>
          <description>BMD precision will be reported across three DXA devices in major skeletal and body composition sites. The short-term precision was calculated as RMS-SD (root mean square standard deviation) over the mean for each cohort. The skeletal cohort will not have short-term precision value for body composition indexes due to the different region of measurement. The same will apply to the body composition cohort. As the result, the &quot;Skeletal &amp; Body Composition&quot; cohort identified in participant flow and overall study summary will not have an analysis provided.</description>
          <units>Percentage of variance</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="70"/>
                <count group_id="O2" value="65"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>iDXA Spine BMD</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.0"/>
                    <measurement group_id="O2" value="NA">This &quot;Skeletal&quot; region of interest is not available in the &quot;Body Composition&quot; cohort.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Prodigy Spine BMD</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.3"/>
                    <measurement group_id="O2" value="NA">This &quot;Skeletal&quot; region of interest is not available in the &quot;Body Composition&quot; cohort.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Discovery A Spine BMD</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.2"/>
                    <measurement group_id="O2" value="NA">This &quot;Skeletal&quot; region of interest is not available in the &quot;Body Composition&quot; cohort.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>iDXA Femural neck BMD</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.5"/>
                    <measurement group_id="O2" value="NA">This &quot;Skeletal&quot; region of interest is not available in the &quot;Body Composition&quot; cohort.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Prodigy Femural neck BMD</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.6"/>
                    <measurement group_id="O2" value="NA">This &quot;Skeletal&quot; region of interest is not available in the &quot;Body Composition&quot; cohort.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Discovery A Femural neck BMD</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.1"/>
                    <measurement group_id="O2" value="NA">This &quot;Skeletal&quot; region of interest is not available in the &quot;Body Composition&quot; cohort.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>iDXA Total Femur BMD</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.8"/>
                    <measurement group_id="O2" value="NA">This &quot;Skeletal&quot; region of interest is not available in the &quot;Body Composition&quot; cohort.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Prodigy Total Femur BMD</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.8"/>
                    <measurement group_id="O2" value="NA">This &quot;Skeletal&quot; region of interest is not available in the &quot;Body Composition&quot; cohort.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Discovery A Total Femur BMD</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.7"/>
                    <measurement group_id="O2" value="NA">This &quot;Skeletal&quot; region of interest is not available in the &quot;Body Composition&quot; cohort.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>iDXA Total Body BMD</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="NA">This &quot;Body Composition&quot; cohort region of interest is not available in the &quot;Skeletal&quot; cohort.</measurement>
                    <measurement group_id="O2" value="0.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Prodigy Total Body BMD</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="NA">This &quot;Body Composition&quot; cohort region of interest is not available in the &quot;Skeletal&quot; cohort.</measurement>
                    <measurement group_id="O2" value="0.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Discovery A Total Body BMD</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="NA">This &quot;Body Composition&quot; cohort region of interest is not available in the &quot;Skeletal&quot; cohort.</measurement>
                    <measurement group_id="O2" value="1.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>IDXA Trunk BMD</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="NA">This &quot;Body Composition&quot; cohort region of interest is not available in the &quot;Skeletal&quot; cohort.</measurement>
                    <measurement group_id="O2" value="1.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Prodigy Trunk BMD</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="NA">This &quot;Body Composition&quot; cohort region of interest is not available in the &quot;Skeletal&quot; cohort.</measurement>
                    <measurement group_id="O2" value="1.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Discovery A Trunk BMD</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="NA">This &quot;Body Composition&quot; cohort region of interest is not available in the &quot;Skeletal&quot; cohort.</measurement>
                    <measurement group_id="O2" value="5.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>iDXA Leg BMD</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="NA">This &quot;Body Composition&quot; cohort region of interest is not available in the &quot;Skeletal&quot; cohort.</measurement>
                    <measurement group_id="O2" value="0.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Prodigy Leg BMD</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="NA">This &quot;Body Composition&quot; cohort region of interest is not available in the &quot;Skeletal&quot; cohort.</measurement>
                    <measurement group_id="O2" value="1.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Discovery A Leg BMD</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="NA">This &quot;Body Composition&quot; cohort region of interest is not available in the &quot;Skeletal&quot; cohort.</measurement>
                    <measurement group_id="O2" value="1.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Skeletal</title>
          <description>Recruitment for each cohort will include approximately equal male/female split (no gender bias). Depending on the weight category, for each cohort, a minimum of 30 adult subjects will be measured on two of the three systems, and 60 will be measured on all three systems (total of evaluable 90 subjects).</description>
        </group>
        <group group_id="E2">
          <title>Body Composition</title>
          <description>Recruitment for each cohort will include approximately equal male/female split (no gender bias). Depending on the weight category, for each cohort, a minimum of 30 adult subjects will be measured on two of the three systems, and 60 will be measured on all three systems (total of evaluable 90 subjects).</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="70"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="65"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="70"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="65"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Yi Xia</name_or_title>
      <organization>GE Healthcare</organization>
      <phone>1 (608) 221-1551 ext 500-3045</phone>
      <email>Yi.Xia@ge.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

